Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8770090rdf:typepubmed:Citationlld:pubmed
pubmed-article:8770090lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:8770090lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:8770090lifeskim:mentionsumls-concept:C2709248lld:lifeskim
pubmed-article:8770090lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:8770090lifeskim:mentionsumls-concept:C0006560lld:lifeskim
pubmed-article:8770090lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:8770090lifeskim:mentionsumls-concept:C0162337lld:lifeskim
pubmed-article:8770090lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:8770090pubmed:issue2 Pt 2lld:pubmed
pubmed-article:8770090pubmed:dateCreated1996-10-30lld:pubmed
pubmed-article:8770090pubmed:abstractTextIncreased serum concentrations of C-reactive protein (CRP) have previously been shown to downregulate neutrophil (PMN) influx and vascular permeability changes in models of localized inflammation such as alveolitis [R. M. Heuertz, D. Xia, D. Samols, and R. O. Webster, Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L649-L654, 1994]. Experiments in isolated, buffer-perfused rabbit lungs were used to determine whether CRP attenuates vascular lung injury induced by PMNs stimulated with the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine (fMLP). Peritoneal PMN were added to the perfusate of lungs from PMN-depleted rabbits. Stimulation with fMLP produced an immediate and transient rise in pulmonary artery pressure that peaked at 35-40 cmH2O. An increase in permeability occurred 60 min after fMLP, which was marked by a 70% increase (P < 0.05) in filtration coefficient and bronchoalveolar lavage (BAL) protein concentration. CRP pretreatment of PMNs prevented fMLP-induced increases in permeability and significantly reduced the BAL protein below levels in control lungs (P < 0.05). CRP pretreatment of PMNs did not alter the pulmonary arterial pressor response to fMLP and had no effect on the production of leukotrienes, thromboxane, prostacyclin, or superoxide anion induced by fMLP. The mechanism by which CRP protects lung tissue from vascular injury induced by activation of PMNs remains unclear.lld:pubmed
pubmed-article:8770090pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8770090pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8770090pubmed:languageenglld:pubmed
pubmed-article:8770090pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8770090pubmed:citationSubsetIMlld:pubmed
pubmed-article:8770090pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8770090pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8770090pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8770090pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8770090pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8770090pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8770090pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8770090pubmed:statusMEDLINElld:pubmed
pubmed-article:8770090pubmed:monthAuglld:pubmed
pubmed-article:8770090pubmed:issn0002-9513lld:pubmed
pubmed-article:8770090pubmed:authorpubmed-author:DahmsT ETElld:pubmed
pubmed-article:8770090pubmed:authorpubmed-author:WebsterR OROlld:pubmed
pubmed-article:8770090pubmed:authorpubmed-author:AbernathyV...lld:pubmed
pubmed-article:8770090pubmed:issnTypePrintlld:pubmed
pubmed-article:8770090pubmed:volume271lld:pubmed
pubmed-article:8770090pubmed:ownerNLMlld:pubmed
pubmed-article:8770090pubmed:authorsCompleteYlld:pubmed
pubmed-article:8770090pubmed:paginationH507-13lld:pubmed
pubmed-article:8770090pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:meshHeadingpubmed-meshheading:8770090-...lld:pubmed
pubmed-article:8770090pubmed:year1996lld:pubmed
pubmed-article:8770090pubmed:articleTitleC-reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs.lld:pubmed
pubmed-article:8770090pubmed:affiliationDepartment of Anesthesiology, St. Louis University School of Medicine, Missouri 63110, USA.lld:pubmed
pubmed-article:8770090pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8770090pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8770090pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8770090pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8770090lld:pubmed